Location: Home
  • search
  • go
  • Relate News
  • 11/24/2023China Biopharma: Charting a Path to Value Creation (McKinsey)
  • 11/22/2023Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
  • 11/21/2023MNCs Unveil Initiatives at CIIE to Deepen Connection with Chinese Pati...
  • 11/20/2023Roche to Further Explore China's Personalized Healthcare Market Poten...
  • 11/20/2023Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
  • 11/13/2023MSD Takes Over AstraZeneca as the Top MNC in China Q3/2023
  • 11/10/2023China's Strength Is Innovation on Innovation, Western Partners Are Lin...
  • 11/9/2023AstraZeneca Reports Q3/2023 Performance with Dwindling China Revenue G...
  • 11/8/2023Chinese and Foreign Pharma, MedTech Firms Discuss Cooperation at CIIE
  • 11/8/2023The Growing Pains of Chinese Biotech (In Vivo Citeline)
  • 11/6/2023486 A-Listed MedPharma Cos Report Performance in First Three Quarters ...
  • 10/29/2023SMEI: Chinese Terminal Drug Market Growth Rose 10.4% in H1/2023
  • 10/25/2023Kyowa Kirin Expands Production Capacity in China
  • 10/24/2023MIIT: Chinese Pharma Industry Up 9.3% in 14th FYP Period
  • 10/15/2023Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
  • 10/15/2023The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
  • 10/12/2023Review of Chinese Biopharma Industry Performance in September 2023
  • 10/10/2023Bayer Pledges to Make More Investment in China
  • 10/10/2023China Market Opportunities for International Pharmas (Lek)
  • 10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
  • 10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • 9/17/2023In China's Changing Economy, MNCs Must Rethink the Mantra of Going Big...
  • 9/15/2023U.S. and Other Foreign Venture Firms Pull Back From China's Biotech Se...
  • 9/13/2023Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
  • 8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • Page:6/39 Total number of articles:1160: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group